Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Corindus Vascular Robotics, Inc. (CVRS)
|
Add to portfolio |
|
|
|
| Price: |
$4.27
| | Metrics |
| OS: |
208.1
|
M
| |
-218
|
% ROE
|
| Market cap: |
$889
|
M
| |
-1274
|
% ROIC
|
|
Net cash:
|
$17.6
|
M
| |
$0.08
|
per share
|
|
EV:
|
$871
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($33.3)
|
M
| |
|
|
|
EBIT
|
($34.3)
|
M
| |
|
|
| EPS |
($8,353.15)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Mar-31-14 | Dec-31-13 | Mar-31-13 |
| Revenues | 10.8 | 9.7 | 2.8 | 2.7 | 3.0 | 0.0 | 0.9 | 0.2 |
| Revenue growth | 11.7% | 239.5% | 4.1% | -8.5% | 232.9% | -79.5% | 343.6% | -99.9% |
| Cost of goods sold | 8.7 | 9.3 | 5.0 | 3.7 | 4.9 | 0.1 | 2.4 | 0.2 |
| Gross profit | 2.1 | 0.4 | -2.2 | -1.0 | -1.9 | 0.0 | -1.5 | 0.0 |
| Gross margin | 19.6% | 4.0% | -77.4% | -36.5% | -64.4% | -60.3% | -171.2% | -20.8% |
| Selling, general and administrative | 27.3 | 24.8 | 19.6 | 16.1 | 13.0 | 0.2 | 8.2 | 0.1 |
| Research and development | 8.8 | 9.5 | 10.3 | 10.0 | 6.6 | | 4.8 | |
| General and administrative | | | | | | 0.1 | | 0.1 |
| EBITA | -34.0 | -33.9 | -32.1 | -27.2 | -21.5 | -0.2 | -14.5 | -0.2 |
| EBITA margin | -315.0% | -351.4% | -1128.7% | -995.6% | -721.8% | -669.7% | -1623.7% | -101.1% |
| Amortization of intangibles | | | | | | 0.0 | | 0.0 |
| EBIT | -34.0 | -33.9 | -32.1 | -27.2 | -21.5 | -0.2 | -14.5 | -0.2 |
| EBIT margin | -315.0% | -351.4% | -1128.7% | -995.6% | -721.8% | -694.7% | -1623.7% | -106.2% |
| Pre-tax income | -35.0 | -34.1 | -33.1 | -28.8 | -24.5 | -0.3 | -14.7 | -0.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -42.6 | -34.1 | -33.1 | -28.8 | -24.5 | -0.3 | -14.7 | -0.2 |
| Net margin | -395.5% | -353.6% | -1163.9% | -1054.0% | -822.7% | -743.6% | -1639.6% | -108.0% |
| |
| Diluted EPS | ($0.22) | ($0.20) | ($0.28) | ($0.25) | ($0.29) | ($0.01) | ($0.20) | $0.00 |
| Shares outstanding (diluted) | 193.8 | 170.6 | 119.0 | 113.3 | 85.0 | 52.0 | 73.4 | 52.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|